Neuronetics
Price & Volume
Stats
See moreOpen | $2.92 |
Previous Close | $2.94 |
Day Range | $2.81-$2.95 |
52W Range | $0.52-$5.92 |
Market Cap | $194.4M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $111.1M |
Revenue Growth (YoY) | 131.7% |
Gross Profit (12 Mos) | $62.9M |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • 23 days ago
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
Yahoo Finance • 2 months ago
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Canaccord Genuity lowers Neuronetics stock price target on margin concerns
Yahoo Finance • 2 months ago
Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises
About
CEO | Mr. Keith J. Sullivan |
CFO | Mr. Steven E. Pfanstiel C.M.A., M.B.A. |
Address | 3222 Phoenixville Pike, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 716 |
